JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review-Reference-Cited by-同舟云学术

JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review

Published:2023-03-31 Issue:4 Volume:16 Page:279-295
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Muddebihal Aishwarya¹^ORCID,Khurana Ananta²^ORCID,Sardana Kabir²^ORCID

Affiliation:

1. Department of Dermatology, Venereology and Leprosy, North Delhi Municipal Corporation Medical College and Hindu Rao Hospital, Delhi, India

2. Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital, New Delhi, India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2193682

Reference142 articles.

1. JAK inhibitors in dermatology: The promise of a new drug class

2. Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins

3. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

4. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention

5. Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Effectiveness of low-dose methotrexate monotherapy in post-essential thrombocythemia myelofibrosis;Frontiers in Medicine;2024-04-18

2. Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up;Journal of Asthma and Allergy;2024-04

3. Exploring Therapeutic Approaches for Vitiligo: An Inclusive Review from Translational Modalities to Alternative Therapies;Current Dermatology Reports;2024-03-14

4. JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature;Cancers;2024-02-21

5. Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review;Journal of Dermatological Treatment;2024-01-23